Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open-Label, Crossover Study In Healthy Volunteers To Evaluate The Pharmacokinetics Of Sildenafil Following Administration Of Three Orally Disintegrating Tablet Formulations Of Sildenafil Without Water Relative To Viagra(TM) Conventional Oral Tablet With Water.

Next Previous
Trial Profile

An Open-Label, Crossover Study In Healthy Volunteers To Evaluate The Pharmacokinetics Of Sildenafil Following Administration Of Three Orally Disintegrating Tablet Formulations Of Sildenafil Without Water Relative To Viagra(TM) Conventional Oral Tablet With Water.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 02 Feb 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Diastolic heart failure; Erectile dysfunction; Heart failure; Pulmonary arterial hypertension; Pulmonary hypertension
  • Focus Pharmacokinetics
  • Sponsors Pfizer

Most Recent Events

  • 07 Oct 2009 Actual initiation date (Aug 2009) added as reported by ClinicalTrials.gov.
  • 07 Oct 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
  • 03 Sep 2009 Planned initiation date changed from 1 Aug 2009 to 1 Sep 2009 as reported by ClinicalTrials.gov

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top